MAXCYTE, INC. Quarterly Operating Margin in % from Q4 2021 to Q2 2024
-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Maxcyte, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q2 2024.
- Maxcyte, Inc. Operating Margin for the quarter ending June 30, 2024 was -102 %, a 1.8% decline year-over-year.
- Maxcyte, Inc. annual Operating Margin for 2023 was -117 %, a 89.2% decline from 2022.
- Maxcyte, Inc. annual Operating Margin for 2022 was -61.8 %, a 15.2% decline from 2021.
- Maxcyte, Inc. annual Operating Margin for 2021 was -53.7 %, a 27% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)